US Bancorp
STOK icon

US Bancorp’s Stoke Therapeutics STOK Stock Holding History

US Bancorp’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.98K Sell
244
-21
-8% -$674 ﹤0.01% 3522
2026
Q1 		$8.63K Buy
265
+21
+9% +$689 ﹤0.01% 3407
2025
Q4 		$7.75K Hold
244
– – ﹤0.01% 3410
2025
Q3 		$5.73K Sell
244
-15
-6% -$257 ﹤0.01% 3497
2025
Q2 		$2.94K Sell
259
-10,963
-98% -$104K ﹤0.01% 3783
2025
Q1 		$74.6K Buy
11,222
+11,108
+9,744% +$104K ﹤0.01% 2538
2024
Q4 		$1.26K Sell
114
-70
-38% -$860 ﹤0.01% 3930
2024
Q3 		$2.26K Sell
184
-212
-54% -$3K ﹤0.01% 3762
2024
Q2 		$5.35K Buy
+396
New +$5.35K ﹤0.01% 3488
2023
Q4 		– Sell
-538
Closed -$2.12K – 4146
2023
Q3 		$2.12K Sell
538
-283
-34% -$1.86K ﹤0.01% 3644
2023
Q2 		$8.73K Sell
821
-80
-9% -$851 ﹤0.01% 3311
2023
Q1 		$7.5K Buy
901
+410
+84% +$3.7K ﹤0.01% 3387
2022
Q4 		$4.53K Sell
491
-944
-66% -$9.82K ﹤0.01% 3540
2022
Q3 		$18K Sell
1,435
-79
-5% -$1.26K ﹤0.01% 3081
2022
Q2 		$20K Buy
1,514
+1,151
+317% +$17.5K ﹤0.01% 3052
2022
Q1 		$8K Buy
363
+242
+200% +$4.85K ﹤0.01% 3471
2021
Q4 		$3K Buy
+121
New +$2.89K ﹤0.01% 3829
2020
Q4 		– Sell
-600
Closed -$20K – 3878
2020
Q3 		$20K Hold
600
– – ﹤0.01% 2818
2020
Q2 		$14K Hold
600
– – ﹤0.01% 2983
2020
Q1 		$14K Buy
+600
New +$14.8K ﹤0.01% 2909

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

US Bancorp's STOK Position: Q2 2026 in Review

US Bancorp reduced its Stoke Therapeutics (STOK) stake by 7.9% in Q2 2026, selling an estimated $674 and leaving 244 shares worth $7.98K. The position accounts for ﹤0.01% of the portfolio, ranked #3522.

US Bancorp first reported a position in STOK in Q1 2020 and has held it in 20 quarters since. The position peaked at $74.6K in Q1 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • US Bancorp held 244 shares of Stoke Therapeutics worth $7.98K as of Q2 2026.
  • US Bancorp sold 21 Stoke Therapeutics shares in Q2 2026, an estimated $674.
  • Stoke Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3522 holding.
  • US Bancorp first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 20 quarters since.
  • US Bancorp's Stoke Therapeutics position peaked at $74.6K in Q1 2025.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.